Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 24;2(10):e1056.
doi: 10.1371/journal.pone.0001056.

Neutrophil activation status in stable coronary artery disease

Eva Särndahl  1 , Ida Bergström, Veronika Patcha Brodin, Johnny Nijm, Helen Lundqvist Setterud, Lena Jonasson
Affiliations

Neutrophil activation status in stable coronary artery disease

Eva Särndahl et al. PLoS One. .

Abstract

Background: During the last years, neutrophils have emerged as important players in atherogenesis. They are highly activated in peripheral blood of patients with unstable angina. Moreover, a primed state of circulating neutrophils has been proposed in patients with stable angina. Our aim was to investigate the neutrophil activation status in patients with stable coronary artery disease (CAD) at conventional drug treatment.

Methodology and principal findings: Thirty patients with stable CAD and 30 healthy controls were included using a paired design. The neutrophil expression of CD18 and high-affinity state of CD11b was analysed by flow cytometry before and after stimulation with chemoattractants. Also, the production of reactive oxygen species (ROS) was determined by chemiluminescence. During basal conditions, the neutrophil expression of CD18 or high-affinity state of CD11b did not differ between patients and controls. Chemoattractants (Interleukin-8 and Leukotriene B(4)) did not increase either the expression or the amount of high-affinity CD11b/CD18-integrins in CAD patients compared to controls, and had no effect on the production of ROS. On the other hand, the ROS production in response to C3bi-opsonised yeast particles and the neutrophils' inherent capacity to produce ROS were both significantly decreased in patients.

Conclusion/significance: We could not find any evidence that neutrophils in patients with stable CAD were primed, i.e. more prone to activation, compared to cells from healthy controls. According to our data, the circulating neutrophils in CAD patients rather showed an impaired activation status. It remains to be elucidated whether the neutrophil dysfunction in CAD is mainly a marker of chronic disease, an atherogenic factor or a consequence of the drug treatment.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Baseline expression of CD18 and high-affinity state CD11b on neutrophils in patients with stable CAD.
Whole blood from patients (P) and individually matched control persons (C) were incubated at 37°C with (A,C) the MHM23-antibody or with (B,D) the CBRM1/5-antibody for 5 and 10 min, respectively, whereafter the samples were incubated on ice. Contaminating erythrocytes were removed by lysis, and antibody bound to CD18 or to CD11b-integrins displaying the high-affinity epitope was detected by FACS analysis. The cells were gated to identify the neutrophil population, and 10 000 cells were analyzed in each sample. Data are shown as one representative histogram plot (A,B) or as median of the mean fluorescence intensity (MFI) values (C,D) from 30 (A,C) and 25 (B,D) experiments per cohort done in triplicate. Mean value is indicated as a black hyphen. Wilcoxon signed-ranks test was used to determine significance between each patient and its individually matched control.
Figure 2
Figure 2. IL-8 and LTB4 induced expression of CD18 on neutrophils from patients with stable CAD.
Whole blood from patients (P) and individually matched control persons (C) were stimulated for 10 min at 37°C with (A,C) IL-8 (10 ng/mL) or (B,D) LTB4 (100 nM), and the samples were co-incubated with the MHM23-antibody during the last 5 min of stimulation. The stimulation was stopped by incubation the samples on ice, and contaminating erythrocytes were removed by lysis. Antibody bound to CD18 was detected by FACS analysis. The cells were gated to identify the neutrophil population, and 10 000 cells were counted in each sample. Data are shown as one representative histogram plot (A,B) or as median of the mean fluorescence intensity (MFI) values (C,D) from 22 (A,C) and 30 (B,D) experiments per cohort done in triplicate. Mean value is indicated as a black hyphen. Wilcoxon signed-ranks test was used to determine significance between each patient and its individually matched control.
Figure 3
Figure 3. IL-8 and LTB4-induced expression of high-affinity state CD11b on neutrophils from patients with stable CAD.
(A–D) Whole blood from patients (P) and individually matched control persons (C) were incubated for 1 min with CBRM1/5 at 37°C, before stimulated for 10 min with (A–B) IL-8 (10 ng/mL) or (C–D) LTB4 (100 nM) at 37°C. The stimulation was stopped by incubating the samples on ice, and contaminating erythrocytes were removed by lysis. Antibody recognizing integrins displaying the high-affinity epitope was detected by FACS analysis. The cells were gated to identify the neutrophil population, and 10 000 cells were counted in each sample. Data are shown as one representative histogram plot (A,C) or as median of the mean fluorescence intensity (MFI) values (B,D) from 20 (A–B) and 25 (C–D) experiments per cohort done in triplicate. (E–F) Isolated neutrophils from patients and control persons were stimulated with C3bi-opsonized yeast particles (5×106/mL), and the production of ROS was measured continuously for 60 min at 37°C. Data are expressed as counts per min (cpm) and shown as one representative histogram plot (E) or as total ROS production peak value from 10 experiments per cohort (F). Mean value is indicated as a black hyphen. Wilcoxon signed-ranks test was used to determine significance between each patient and its individually matched control (** represents significant difference; p<0.01).
Figure 4
Figure 4. IL-8 and LTB4 induced ROS production in neutrophils from patients with stable CAD.
The production of ROS in response to (A–B) IL-8 (100 ng/mL), (C–D) LTB4 (100 nM), or (E–F) PMA (50 nM), was measured in isolated neutrophils from patients (black dashed line and black dot, respectively) and individually matched controls (grey line and grey dot, respectively). Data are expressed as counts per min (cpm) and shown as one representative histogram plot (A,C,E) or as total ROS production peak value from 9–10 experiments per cohort (B,D,F). Mean value is indicated as a black hyphen. Wilcoxon signed-ranks test was used to determine significance between each patient and its individually matched control (** represents significant difference; p<0.01).
Figure 5
Figure 5. A representative gating to identify the neutrophil population in the flow cytometry analysis.
G: Granulocytes, M: Monocytes, L: Lymphocytes, FSC: Forward scatter, SSC: Side scatter.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 1996;94:1239–1246. - PubMed
    1. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, et al. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347:5–12. - PubMed
    1. Patel PB, Pfau SE, Cleman MW, Brennan JJ, Howes C, et al. Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. Am J Cardiol. 2004;93:410–413. - PubMed
    1. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894–2900. - PubMed
    1. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945–1956. - PubMed

Publication types